136 related articles for article (PubMed ID: 9435440)
1. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
Nishimura M; Nakano K; Ushiyama M; Nanbu A; Ohtsuka K; Takahashi H; Yoshimura M
J Clin Endocrinol Metab; 1998 Jan; 83(1):195-8. PubMed ID: 9435440
[TBL] [Abstract][Full Text] [Related]
2. [Neovascularization and HGF: neovascularization in proliferative diabetic retinopathy and intraocular HGF].
Nishimura M; Ushiyama M; Nanbu A; Yoshimura M
Rinsho Byori; 1998 Nov; 46(11):1156-61. PubMed ID: 9868302
[TBL] [Abstract][Full Text] [Related]
3. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
Nishimura M; Ikeda T; Ushiyama M; Nanbu A; Kinoshita S; Yoshimura M
J Clin Endocrinol Metab; 1999 Feb; 84(2):659-62. PubMed ID: 10022434
[TBL] [Abstract][Full Text] [Related]
4. [Serum hepatocyte growth factor as a possible indicator of vascular lesions].
Nishimura M; Ushiyama M; Yoshimura M
Rinsho Byori; 1997 Sep; 45(9):831-6. PubMed ID: 9311255
[TBL] [Abstract][Full Text] [Related]
5. [Vascular endothelium-related factors and atherosclerosis/arteriosclerosis: serum hepatocyte growth factor as a possible indicator of vascular lesions].
Nishimura M; Ushiyama M; Nanbu A; Ohtsuka K; Yoshimura M
Rinsho Byori; 1998 Jul; 46(7):671-7. PubMed ID: 9721534
[TBL] [Abstract][Full Text] [Related]
6. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
[TBL] [Abstract][Full Text] [Related]
7. Association of human hepatocyte growth factor with hemodialysis hypotension.
Nishimura M; Ushiyama M; Maruyama Y; Mabuchi H; Takahashi H; Yoshimura M
Hypertens Res; 2000 Nov; 23(6):581-6. PubMed ID: 11131269
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor as a possible indicator of vascular lesions.
Nishimura M; Ushiyama M; Ohtsuka K; Nishida M; Inoue N; Matsumuro A; Mineo T; Yoshimura M
J Clin Endocrinol Metab; 1999 Jul; 84(7):2475-80. PubMed ID: 10404823
[TBL] [Abstract][Full Text] [Related]
9. Is leptin associated with diabetic retinopathy?
Uckaya G; Ozata M; Bayraktar Z; Erten V; Bingol N; Ozdemir IC
Diabetes Care; 2000 Mar; 23(3):371-6. PubMed ID: 10868868
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy.
Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
Endokrynol Pol; 2008; 59(1):2-5. PubMed ID: 18335393
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of factors associated with proliferative diabetic retinopathy.
Hanna AK; Roy M; Zinman B; McCulloch JC; Mortimer C; Falk JA; Chipman M; Gordon AS; Marliss EB
Clin Invest Med; 1985; 8(2):109-16. PubMed ID: 3833435
[TBL] [Abstract][Full Text] [Related]
12. Pentosidine - a new biochemical marker in diabetic retinopathy.
Salman AG; Mansour DE; Swelem AH; Al-Zawahary WM; Radwan AA
Ophthalmic Res; 2009; 42(2):96-8. PubMed ID: 19546600
[TBL] [Abstract][Full Text] [Related]
13. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
[TBL] [Abstract][Full Text] [Related]
14. Somatomedin-C and diabetic retinopathy.
Sato K; Ikeda T; Miki T; Nishizawa Y; Morii H
Jpn J Ophthalmol; 1988; 32(2):219-22. PubMed ID: 3184555
[TBL] [Abstract][Full Text] [Related]
15. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
[TBL] [Abstract][Full Text] [Related]
16. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
[TBL] [Abstract][Full Text] [Related]
17. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
18. Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.
Mäkimattila S; Summanen P; Matinlauri I; Mäntysaari M; Schlenzka A; Aalto M; Irjala K; Yki-Järvinen H
Br J Ophthalmol; 1998 Aug; 82(8):939-44. PubMed ID: 9828782
[TBL] [Abstract][Full Text] [Related]
19. Serum and tear levels of nerve growth factor in diabetic retinopathy patients.
Park KS; Kim SS; Kim JC; Kim HC; Im YS; Ahn CW; Lee HK
Am J Ophthalmol; 2008 Mar; 145(3):432-7. PubMed ID: 18282491
[TBL] [Abstract][Full Text] [Related]
20. Serum IGF-1 concentration in diabetic retinopathy.
Hyer SL; Sharp PS; Brooks RA; Burrin JM; Kohner EM
Diabet Med; 1988; 5(4):356-60. PubMed ID: 2968886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
